Edition:
United States

Lennox International Inc (LII.N)

LII.N on New York Stock Exchange

209.71USD
23 Feb 2018
Change (% chg)

$3.63 (+1.76%)
Prev Close
$206.08
Open
$207.68
Day's High
$210.23
Day's Low
$207.53
Volume
80,166
Avg. Vol
86,821
52-wk High
$222.31
52-wk Low
$160.18

Chart for

About

Lennox International Inc. is a provider of climate control solutions. The Company designs, manufactures and markets a range of products for the heating, ventilation, air conditioning and refrigeration (HVACR) markets. It operates through three segments: Residential Heating & Cooling; Commercial Heating & Cooling, and Refrigerati... (more)

Overall

Beta: 1.17
Market Cap(Mil.): $8,635.18
Shares Outstanding(Mil.): 41.18
Dividend: 0.51
Yield (%): 0.97

Financials

  Industry Sector
P/E (TTM): -- 28.09 16.59
EPS (TTM): -- -- --
ROI: -- 11.06 35.07
ROE: -- 13.19 17.79

BRIEF-Lennox International Q4 EPS $1.02 From Continuing Operations

* LENNOX INTERNATIONAL REPORTS RECORD FOURTH QUARTER MARGIN AND PROFIT TO CAP RECORD YEAR AND RAISES 2018 EPS GUIDANCE FOR U.S. TAX LEGISLATION

Feb 06 2018

BRIEF-Ovid Therapeutics Announces TAK-935/OV935 Granted Orphan Drug Designation By U.S. FDA For Treatment Of Lennox-Gastaut Syndrome

* OVID THERAPEUTICS ANNOUNCES TAK-935/OV935 GRANTED ORPHAN DRUG DESIGNATION BY U.S. FDA FOR TREATMENT OF LENNOX-GASTAUT SYNDROME

Dec 20 2017

BRIEF-Lennox International Sees Fy18 Revenue Up 3 To 7 Percent

* REAFFIRMS FY 2017 ADJUSTED EARNINGS PER SHARE VIEW $7.75 TO $8.05 FROM CONTINUING OPERATIONS

Dec 13 2017

BRIEF-Lennox International says Lpac, co entered into amendment to amended, restated receivables purchase agreement initially dated Nov 18, 2011

* Lennox International - ‍as of Nov 13, Lennox, Lpac, co entered into amendment to amended, restated receivables purchase agreement initially dated nov 18, 2011

Nov 16 2017

Earnings vs. Estimates